Recommendation |
sources |
WHO/IARC/RITA |
NACAD |
STP |
hyperplasia, pars intermedia (H) |
hyperplasia, pars intermedia (H) |
hyperplasia, pars intermedia (H) |
hyperplasia, pars intermedia |
adenoma, pars intermedia (B) |
adenoma, pars intermedia (B) |
adenoma, pars intermedia (B) |
adenoma, pars intermedia |
hyperplasia, pars distalis (H) |
hyperplasia, pars distalis (H) |
hyperplasia, pars distalis (H) |
hyperplasia, pars distalis |
adenoma, pars distalis (B) |
adenoma, pars distalis (B) |
adenoma, pars distalis (B) |
adenoma, pars distalis |
carcinoma, pars distalis (M) |
adenocarcinoma, pars distalis (M) |
carcinoma, pars distalis (M) |
carcinoma, pars distalis |
craniopharyngioma, benign (B) |
craniopharyngioma, benign (B) |
craniopharyngioma, benign (B) |
|
craniopharyngioma, malignant (M) |
craniopharyngioma, malignant (M) |
craniopharyngioma, malignant (M) |
|
|
|
|
craniopharyngioma |
pituicytoma (B) |
pituicytoma (B) |
pituicytoma (B) |
pituicytoma, pars nervosa |